What are the major opportunities in the Asthma Disease market? What are the strategies for the Asthma Disease market?

For detailed insights on the major opportunities and strategies in the Asthma Disease market, Read More

How does the Asthma Disease market relate to the overall economy and other similar markets?

For detailed insights on Asthma Disease's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Asthma Disease market growth? SWOT analysis of the Asthma Disease market.

For detailed insights on the key dynamics influencing the Asthma Disease market growth and SWOT analysis of the Asthma Disease industry, Read More

Global Asthma Disease Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Asthma Disease Global Market Report 2025

Name: Asthma Disease Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Controller Medications, Rescue Medications, Biologics, Combination Therapy), By Cause Of Asthma (Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma), By Severity (Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent ), By Route Of Administration (Oral, Inhaled, Intravenous, Other Route Of Administration), By End-Users (Hospitals, Homecare, Specialty Clinics , Others End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Asthma Disease Market Overview

• Asthma Disease market size has reached to $24.63 billion in 2024

• Expected to grow to $31.56 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%

• Growth Driver: Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution

• Market Trend: Monoclonal Antibody Therapies Advancing Asthma For High-Risk Youth

• North America was the largest region in 2024.

What Is Covered Under Asthma Disease Market?

Asthma disease refers to a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. It involves airflow obstruction that is often reversible either spontaneously or with treatment and is associated with airway hyperresponsiveness to various stimuli such as allergens, exercise, or cold air.

The main treatment types of asthma disease are controller medications, rescue medications, biologics, and combination therapy. Controller medications refer to long-term asthma management drugs that are taken daily to prevent asthma symptoms and attacks. The multiple causes of asthma are allergic asthma, non-allergic asthma, exercise-induced asthma, and occupational asthma. The various severities include mild intermittent, mild persistent, moderate persistent, and severe persistent. The several routes of administration include oral, inhaled, intravenous, and others, and are used by various end users such as hospitals, homecare, specialty clinics, and others.

Asthma Disease Market Size and growth rate 2025 to 2029: Graph

What Is The Asthma Disease Market Size 2025 And Growth Rate?

The asthma disease market size has grown strongly in recent years. It will grow from $24.63 billion in 2024 to $25.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of asthma in urban populations, increasing air pollution levels in industrialized regions, growing awareness about asthma symptoms and diagnosis, rising use of corticosteroids and bronchodilators, and expanding healthcare access in developing nations.

What Is The Asthma Disease Market Growth Forecast?

The asthma disease market size is expected to see strong growth in the next few years. It will grow to $31.56 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing adoption of biologics for severe asthma, growing demand for personalized medicine, rising investments in asthma research, increasing digital health and remote monitoring adoption, and expanding telemedicine services for asthma management. Major trends in the forecast period include advancement in biologic therapies for severe asthma, advanced inhaler technologies with smart features, development of AI-based asthma monitoring tools, innovation in personalized asthma treatment approaches, and development of digital health platforms for remote asthma management.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Asthma Disease Market Segmented?

1) By Treatment Type: Controller Medications, Rescue Medications, Biologics, Combination Therapy

2) By Cause Of Asthma: Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma

3) By Severity: Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent

4) By Route Of Administration: Oral, Inhaled, Intravenous, Other Route Of Administration

5) By End-Users: Hospitals, Homecare, Specialty Clinics , Others End-Users

Subsegments:

1) By Controller Medications Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines

2) By Rescue Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics

3) By Biologics: Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy

4) By Combination Therapy: ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations

What Is Driving The Asthma Disease Market? Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution

The rising prevalence of respiratory disorders is expected to propel the growth of the asthma disease market going forward. Respiratory disorders refer to a group of diseases that affect the lungs and breathing, including chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. The increasing prevalence of respiratory disorders is due to particulate matter and nitrogen oxides irritating and inflaming the airways, leading to breathing difficulties and worsening conditions such as asthma. Respiratory diseases can cause inflammation and airway remodeling, which trigger or worsen asthma symptoms. For instance, in December 2023, according to the National Library of Medicine, a US-based national library, by 2050, chronic obstructive pulmonary disease (COPD) cases in low- and middle-income countries are projected to more than double those in high-income countries, with sub-Saharan Africa expected to see a 59% increase and lead globally in COPD prevalence and cases by 2040. Therefore, the rising prevalence of respiratory disorders is driving the growth of the asthma disease industry.

Who Are The Major Players In The Global Asthma Disease Market?

Major companies operating in the asthma disease market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, Generate Biomedicines.

What Are The Key Trends Of The Global Asthma Disease Market? Monoclonal Antibody Therapies Advancing Asthma For High-Risk Youth

Major companies operating in the asthma disease market are focusing on developing solutions such as monoclonal antibody therapies to enhance treatment efficacy and patient outcomes. Monoclonal antibody therapy refers to a form of targeted treatment that uses laboratory-made proteins to mimic the immune system’s ability to fight off harmful pathogens, offering more precise and effective management of chronic conditions such as asthma. For instance, in June 2022, the National Institutes of Health (NIH), a US-based medical research agency, launched the PANDA trial (preventing asthma in high-risk kids) to evaluate the monoclonal antibody dupilumab as a treatment for asthma in urban youth. The PANDA trial is a Phase 2, randomized, placebo-controlled study evaluating dupilumab in approximately 240 children aged 6–17 with poorly controlled, type 2 inflammation, high allergic asthma living in low-income urban areas. Participants receive subcutaneous injections every two weeks for one year alongside standard asthma care, with a 2:1 randomization to dupilumab or placebo. The trial also includes mechanistic studies using nasal swabs and blood samples to analyze gene expression, particularly during respiratory viral infections, aiming to understand the molecular pathways of asthma exacerbations and treatment response in this high-risk pediatric population.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Asthma Disease Market? GSK Strengthens Respiratory Portfolio With Acquisition Of Aiolos Bio

In January 2024, GSK plc, a UK-based pharmaceutical company, acquired Aiolos Bio Inc. for an undisclosed amount. With this acquisition, GSK aims to strengthen its respiratory treatment portfolio and drive long-term growth by leveraging Aiolos Bio’s innovative therapies and GSK’s global reach to better serve patients worldwide. Aiolos Bio Inc. is a US-based clinical-stage biopharmaceutical company specializing in asthma treatment.

What Is The Regional Outlook For The Global Asthma Disease Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Asthma Disease Industry?

The asthma disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including asthma disease industry global market size, regional shares, competitors with the market share, market segments, market trends and opportunities, and any further data you may need to thrive in the asthma disease industry. This asthma disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Asthma Disease Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$25.93 billion
Revenue Forecast In 2034	$31.56 billion
Growth Rate	CAGR of 5.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Treatment Type, Cause Of Asthma, Severity, Route Of Administration, End-Users, Controller Medications Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Meth
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, Generate Biomedicines.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Asthma Disease Market Characteristics

3. Asthma Disease Market Trends And Strategies

4. Asthma Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Asthma Disease Growth Analysis And Strategic Analysis Framework

5.1. Global Asthma Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Asthma Disease Market Growth Rate Analysis

5.4. Global Asthma Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Asthma Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Asthma Disease Total Addressable Market (TAM)

6. Asthma Disease Market Segmentation

6.1. Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Controller Medications

Rescue Medications

Biologics

Combination Therapy

6.2. Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergic Asthma

Non-Allergic Asthma

Exercise-Induced Asthma

Occupational Asthma

6.3. Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mild Intermittent

Mild Persistent

Moderate Persistent

Severe Persistent

6.4. Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Inhaled

Intravenous

Other Route Of Administration

6.5. Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.6. Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhaled Corticosteroids (ICS)

Long-Acting Beta-Agonists (LABA)

Leukotriene Receptor Antagonists (LTRA)

Long-Acting Muscarinic Antagonists (LAMA)

Methylxanthines

6.7. Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Short-Acting Beta-Agonists (SABA)

Systemic Corticosteroids

Anticholinergics

6.8. Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-IgE Therapy

Anti-IL-5 Therapy

Anti-IL-4/IL-13 Therapy

Anti-TSLP Therapy

6.9. Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

ICS Or LABA Combinations

ICS Or LABA Or LAMA Combinations

ICS Or LAMA Combinations

7. Asthma Disease Market Regional And Country Analysis

7.1. Global Asthma Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Asthma Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Asthma Disease Market

8.1. Asia-Pacific Asthma Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Asthma Disease Market

9.1. China Asthma Disease Market Overview

9.2. China Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Asthma Disease Market

10.1. India Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Asthma Disease Market

11.1. Japan Asthma Disease Market Overview

11.2. Japan Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Asthma Disease Market

12.1. Australia Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Asthma Disease Market

13.1. Indonesia Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Asthma Disease Market

14.1. South Korea Asthma Disease Market Overview

14.2. South Korea Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Asthma Disease Market

15.1. Western Europe Asthma Disease Market Overview

15.2. Western Europe Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Asthma Disease Market

16.1. UK Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Asthma Disease Market

17.1. Germany Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Asthma Disease Market

18.1. France Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Asthma Disease Market

19.1. Italy Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Asthma Disease Market

20.1. Spain Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Asthma Disease Market

21.1. Eastern Europe Asthma Disease Market Overview

21.2. Eastern Europe Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Asthma Disease Market

22.1. Russia Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Asthma Disease Market

23.1. North America Asthma Disease Market Overview

23.2. North America Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Asthma Disease Market

24.1. USA Asthma Disease Market Overview

24.2. USA Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Asthma Disease Market

25.1. Canada Asthma Disease Market Overview

25.2. Canada Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Asthma Disease Market

26.1. South America Asthma Disease Market Overview

26.2. South America Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Asthma Disease Market

27.1. Brazil Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Asthma Disease Market

28.1. Middle East Asthma Disease Market Overview

28.2. Middle East Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Asthma Disease Market

29.1. Africa Asthma Disease Market Overview

29.2. Africa Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Asthma Disease Market Competitive Landscape And Company Profiles

30.1. Asthma Disease Market Competitive Landscape

30.2. Asthma Disease Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Asthma Disease Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi S.A.

31.3. AstraZeneca PLC

31.4. Abbott Laboratories

31.5. GlaxoSmithKline plc

31.6. Eli Lilly and Company

31.7. Amgen Inc.

31.8. Boehringer Ingelheim GmbH

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Regeneron Pharmaceuticals Inc.

31.11. Astellas Pharma Inc.

31.12. Chiesi Farmaceutici S.p.A.

31.13. Cipla Limited

31.14. Mundipharma International Limited

31.15. Generate Biomedicines

32. Global Asthma Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Asthma Disease Market

34. Recent Developments In The Asthma Disease Market

35. Asthma Disease Market High Potential Countries, Segments and Strategies

35.1 Asthma Disease Market In 2029 - Countries Offering Most New Opportunities

35.2 Asthma Disease Market In 2029 - Segments Offering Most New Opportunities

35.3 Asthma Disease Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Asthma Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Asthma Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Financial Performance

Table 82: F. Hoffmann-La Roche Ltd. Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Asthma Disease Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Asthma Disease Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Asthma Disease Market, Sub-Segmentation Of Controller Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Asthma Disease Market, Sub-Segmentation Of Rescue Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Asthma Disease Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Asthma Disease Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Asthma Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Asthma Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Asthma Disease Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Asthma Disease Market, Segmentation By Cause Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Asthma Disease Market, Segmentation By Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Financial Performance

Figure 82: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: AbbVie Inc. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025 – By Type (Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types), B...

Black Lung Disease Global Market Report 2025 – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Ce...

Allergic Rhinitis Global Market Report 2025 – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Decongestants...

Intelligent Asthma Monitoring Devices Global Market Report 2025 – By Product (Wearable Asthma Monitoring Devices, Smart Inhalers, Inhalers, Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers), By Technology (Manual...

Asthma Drugs Global Market Report 2025 – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Noc...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

What is the definition of the Asthma Disease market?

How will the Asthma Disease market drivers and restraints affect the market dynamics? What forces will shape the Asthma Disease industry going forward?

The Asthma Disease market major growth driver - Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution. For further insights on the Asthma Disease market, request a sample here

What is the forecast market size or the forecast market value of the Asthma Disease market?

The Asthma Disease market size has grown strongly in recent years. The asthma disease market size has grown strongly in recent years. It will grow from $24.63 billion in 2024 to $25.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of asthma in urban populations, increasing air pollution levels in industrialized regions, growing awareness about asthma symptoms and diagnosis, rising use of corticosteroids and bronchodilators, and expanding healthcare access in developing nations. The asthma disease market size is expected to see strong growth in the next few years. It will grow to $31.56 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing adoption of biologics for severe asthma, growing demand for personalized medicine, rising investments in asthma research, increasing digital health and remote monitoring adoption, and expanding telemedicine services for asthma management. Major trends in the forecast period include advancement in biologic therapies for severe asthma, advanced inhaler technologies with smart features, development of AI-based asthma monitoring tools, innovation in personalized asthma treatment approaches, and development of digital health platforms for remote asthma management. For further insights on the Asthma Disease market, request a sample here

How is the Asthma Disease market segmented?

The asthma disease market covered in this report is segmented –
1) By Treatment Type: Controller Medications, Rescue Medications, Biologics, Combination Therapy
2) By Cause Of Asthma: Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma
3) By Severity: Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent
4) By Route Of Administration: Oral, Inhaled, Intravenous, Other Route Of Administration
5) By End-Users: Hospitals, Homecare, Specialty Clinics , Others End-Users Subsegments:
1) By Controller Medications Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines
2) By Rescue Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics
3) By Biologics: Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy
4) By Combination Therapy: ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations For further insights on the Asthma Disease market, request a sample here

Which region has the largest share of the Asthma Disease market? What are the other regions covered in the report?

North America was the largest region in the asthma disease market in 2024. The regions covered in the asthma disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Asthma Disease market, request a sample here.

Who are the major players in the Asthma Disease market?

What are the key trends in the Asthma Disease market?

Major trends in the Asthma Disease market include Monoclonal Antibody Therapies Advancing Asthma For High-Risk Youth. For further insights on the Asthma Disease market, request a sample here.